Zahra Ghodratian, Katharina Grikscheit, Loraine Busetto, Benjamin Marx, Niko Kohmer, Arne Auste, Raphael Scheu, Manuela Harries, Vanessa Melhorn, Thomas Illig, Monika Strengert, Annemarie Berger, Berit Lange and Sandra Ciesek

Population-based prevalence and screening gaps of hepatitis C, B and D, Germany, 2020 to 2021

BACKGROUND Chronic hepatitis C (HCV) and hepatitis B (HBV) viruses remain major causes of liver-related morbidity and mortality. Despite a low prevalence in Germany, migration from higher-endemic regions and screening gaps may hinder progress towards World Health Organization (WHO) 2030 elimination targets. Population-based data are needed for surveillance,